enthesopathies

Enthesopathies are disorders affecting the enthesis, the site where tendons, ligaments, and joint capsule fibers attach to bone. The term covers both inflammatory forms, known as enthesitis, and noninflammatory or degenerative changes, referred to as enthesopathy. Entheses are customized, fibrocartilaginous regions that mediate the transition from soft tissue to bone and are especially vulnerable to mechanical stress.

Etiology and pathophysiology vary. Mechanical overload from repetitive use or acute injury can cause microtrauma with degeneration and calcifications at the enthesis. Inflammatory enthesitis occurs in conditions such as seronegative spondyloarthropathies (for example, psoriatic arthritis and ankylosing spondylitis) and inflammatory bowel disease–associated arthritides, where immune-mediated inflammation targets entheseal tissue. Enthesopathy may also feature age-related or metabolic changes, with enthesophyte formation and cartilage loss.

Common sites include the plantar fascia at the heel, the Achilles tendon insertion, lateral and medial Epicondyles of the elbow, greater trochanter, and spinal or pelvic entheses linked to axial spondyloarthropathies. Clinically, patients report focal tenderness at the attachment, pain with tendon or ligament pulling, and activity-related discomfort. In inflammatory enthesitis, morning stiffness and systemic inflammatory features may occur.

Diagnosis relies on clinical assessment supported by imaging and laboratory tests. Ultrasound can show increased enthesis thickness, hypoechogenicity, calcifications, and Doppler signal. MRI may reveal bone marrow edema and enthesitis; radiographs can show enthesophytes or bone spurs. Laboratory studies help identify inflammatory disease (eg, elevated acute-phase reactants; HLA-B27 positivity in certain conditions).

Management is multidisciplinary and site-specific. Mechanical enthesopathy favors activity modification, physical therapy with stretching and eccentric strengthening, orthotics, and NSAIDs as needed. In focal inflammatory enthesitis, corticosteroid injections may be used with caution. Chronic inflammatory enthesitis related to spondyloarthropathies may require disease-modifying antirheumatic or biologic therapies (eg, TNF or IL-17 inhibitors). Prognosis depends on the underlying cause and response to treatment.